Page 46 - Children Program News Today

The shortage of nirsevimab has public health officers frustrated, especially as the nation heads into the winter.

The shortage of nirsevimab has public health officers frustrated, especially as the nation heads into the winter.

The shortage of nirsevimab has public health officers frustrated, especially as the nation heads into the winter.

The shortage of nirsevimab has public health officers frustrated, especially as the nation heads into the winter.

The shortage of nirsevimab has public health officers frustrated, especially as the nation heads into the winter.

Today, CDC announced the release of more than 77,000 additional doses of Beyfortus™ (nirsevimab-alip (100 mg), a long-acting monoclonal antibody designed to protect infants against severe respiratory syncytial virus (RSV) disease.

(The Center Square) – Forty-five U.S. House Republicans voted with Democrats against an amendment to remove an agency head at the center of ongoing allegations of child abuse and neglect.

The CDC released more than 77,000 additional doses of Beyfortus on Thursday, November 16, 2023.

Supplies of monoclonal antibodies that protect infants will remain tight through this season.

By Isabel Ashley